Fig. 1From: Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgerySurvival of patients with locally advanced gastric cancer after radical gastrectomy. a 3-year overall survival; b 3-year relapse-free survivalBack to article page